Melissa Hollo: How HerCare Utilizes Hierarchical Algorithm of Severe Maternal Morbidity
Melissa Hollo, Director of Project Management at hc1 and Licensed Independent Clinical Social Worker, shared a post on LinkedIn:
“A recent study titled ‘Hierarchical algorithm identifies methods of severe maternal morbidity’ by Joshua Fitch, Senior Editor, published in Obstetrics and Gynecology, highlights a significant advancement in our understanding of severe maternal morbidity.
The study emphasizes the need for earlier and more precise identification of risks.
The research introduces a hierarchical algorithm that achieves a 94.5% concordance with manual chart reviews in identifying the primary drivers of maternal morbidity.
Key findings indicate that hemorrhage, hypertension, and infection are major contributors to maternal complications, with hypertension and infection alone responsible for nearly 45% of non-transfusion related cases.
While this study provides clarity on the factors driving maternal morbidity, it also highlights a critical gap in care: risks are often identified only after they have escalated.
At hc1, we are addressing this issue through HerCare.
HerCare utilizes a hierarchical, data-driven approach to identify maternal risk earlier in the care journey, before complications become severe.
By integrating clinical, lab, and longitudinal patient data, we empower providers to proactively detect risks such as iron deficiency, hypertensive disorders, and infections – conditions that significantly contribute to morbidity.
The opportunity lies not just in better classification, but in intervention.
By identifying these risks sooner, we can:
- Improve maternal outcomes and reduce preventable complications
- Decrease costly acute interventions and hospital utilization
- Close the gap between morbidity and mortality drivers through earlier care pathways
We can begin to shift the curve on maternal health by combining clinical insight with actionable intelligence at the point of care.
Learn how we’re supporting earlier maternal risk detection.”
More posts featuring Melissa Hollo on Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care